LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 30

Search options

  1. Article ; Online: Panicolytic-like effects of environment enrichment on male mice threatened by Bothrops jararaca lancehead pit vipers.

    de Paula Rodrigues, Bruno Mangili / Falconi-Sobrinho, Luiz Luciano / de Campos, Alline Cristina / Kanashiro, Alexandre / Coimbra, Norberto Cysne

    Journal of neuroscience research

    2024  Volume 102, Issue 2, Page(s) e25300

    Abstract: Environment enrichment (EE) is a well-known eustress model showing beneficial effects in different psychiatric diseases, but its positive properties in panic disorders are not yet established. The confrontation between prey and predator in complex arenas ...

    Abstract Environment enrichment (EE) is a well-known eustress model showing beneficial effects in different psychiatric diseases, but its positive properties in panic disorders are not yet established. The confrontation between prey and predator in complex arenas has been validated as a putative panic attack model. The principal aim of this work was to investigate the role of the EE on panic-like defensive responses elicited by mice threatened by venomous snakes. After 6 weeks of exposure either to an enriched or standard environments, 36 male mice were habituated in a complex polygonal arena for snakes containing an artificial burrow and elevated platforms for escape. The animals were confronted by Bothrops jararaca for 5 min, and the following antipredatory responses were recorded: defensive attention, stretched attend posture, flat back approach, prey versus predator interaction, oriented escape behavior, time spent in a safe place, and number of crossings. Mice threatened by snakes displayed several antipredatory reactions as compared to the exploratory behavior of those animals submitted to a nonthreatening situation (toy snake) in the same environment. Notably, EE causes anxiolytic- and panicolytic-like effects significantly decreasing the defensive attention and time spent in safe places and significantly increasing both prey versus predator interaction and exploratory behavior. In conclusion, our data demonstrate that EE can alter the processing of fear modulation regarding both anxiety- and panic-like responses in a dangerous condition, significantly modifying the decision-making defensive strategy.
    MeSH term(s) Mice ; Male ; Animals ; Bothrops jararaca ; Crotalinae ; Panic Disorder ; Fear ; Panic/physiology
    Language English
    Publishing date 2024-02-15
    Publishing country United States
    Document type Journal Article
    ZDB-ID 195324-2
    ISSN 1097-4547 ; 0360-4012
    ISSN (online) 1097-4547
    ISSN 0360-4012
    DOI 10.1002/jnr.25300
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Environmental Enrichment Facilitates Anxiety in Conflict-Based Tests but Inhibits Predator Threat-Induced Defensive Behaviour in Male Mice.

    Dos Anjos-Garcia, Tayllon / Kanashiro, Alexandre / de Campos, Alline Cristina / Coimbra, Norberto Cysne

    Neuropsychobiology

    2022  Volume 81, Issue 3, Page(s) 225–236

    Abstract: Introduction: Environmental enrichment (EE) is a useful and sophisticated tool that improves rodents' well-being by stimulating social behaviour and cognitive, motor, and sensory functions. Exposure to EE induces neuroplasticity in different brain areas, ...

    Abstract Introduction: Environmental enrichment (EE) is a useful and sophisticated tool that improves rodents' well-being by stimulating social behaviour and cognitive, motor, and sensory functions. Exposure to EE induces neuroplasticity in different brain areas, including the limbic system, which has been implicated in the control of anxiety and fear. However, the effects of EE on ethologically relevant naturalistic behaviours, such as those displayed by prey in the presence of predators, remain largely unexplored.
    Material and methods: In the present study, we investigated anxiety- and panic attack-like behaviours in a predator (cat)-prey confrontation paradigm and compared them with those in classical assays, such as the elevated plus-maze (EPM), marble-burying, and open field tests (OFTs), using C57BL/6J male mice housed in enriched or standard environments for 6 weeks.
    Results: We observed that EE exposure caused enhancement of the levels of anxiety-like behaviours in the EPM and OFTs, increasing risk assessment (an anxiety-related response), and decreasing escape (a panic attack-like response) behaviours during exposure to the predator versus prey confrontation paradigm.
    Conclusion: Taken together, our findings suggest that enriched external environments can modify the processing of fear- and anxiety-related stimuli in dangerous situations, changing the decision-making defensive strategy.
    MeSH term(s) Animals ; Anxiety ; Anxiety Disorders/psychology ; Behavior, Animal/physiology ; Fear/physiology ; Fear/psychology ; Humans ; Male ; Mice ; Mice, Inbred C57BL ; Panic Disorder
    Language English
    Publishing date 2022-01-13
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 442239-9
    ISSN 1423-0224 ; 0302-282X
    ISSN (online) 1423-0224
    ISSN 0302-282X
    DOI 10.1159/000521184
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Sex and estrous cycle-linked differences in the effect of cannabidiol on panic-like responding in rats and mice.

    Hernandes, Paloma Molina / Batistela, Matheus Fitipaldi / Nascimento-Silva, Jefferson Manoel / Frias, Alana Tercino / Matthiesen, Melina / Campos, Alline Cristina / Lovick, Thelma Anderson / Zangrossi, Helio

    Behavioural brain research

    2023  Volume 455, Page(s) 114663

    Abstract: Clinical and preclinical studies point towards anxiolytic actions of cannabidiol (CBD), but its effect in panic disorder has been less explored and few studies consider effects in females. We here compared the effect of CBD on the response of male and ... ...

    Abstract Clinical and preclinical studies point towards anxiolytic actions of cannabidiol (CBD), but its effect in panic disorder has been less explored and few studies consider effects in females. We here compared the effect of CBD on the response of male and female rats and mice to a panicogenic challenge; exposure to low O
    Language English
    Publishing date 2023-09-11
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 449927-x
    ISSN 1872-7549 ; 0166-4328
    ISSN (online) 1872-7549
    ISSN 0166-4328
    DOI 10.1016/j.bbr.2023.114663
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Neonatal maternal deprivation facilitates the expression of a panic-like escape behavior in adult rats.

    Rosa, Daiane Santos / Frias, Alana Tercino / Vilela-Costa, Heloísa Helena / Spiacci, Ailton / Sant'Ana, Ana Beatriz / Fusse, Eduardo Junji / Suchecki, Deborah / Campos, Alline Cristina / Lovick, Thelma Anderson / Zangrossi, Hélio

    Behavioural brain research

    2022  Volume 434, Page(s) 114031

    Abstract: A wealth of evidence associates disruptions of the parent-infant relationship (e.g. childhood parental loss or parental neglect) with the later appearance of panic disorder. In rodents, neonatal maternal separation and maternal deprivation (MD) are ... ...

    Abstract A wealth of evidence associates disruptions of the parent-infant relationship (e.g. childhood parental loss or parental neglect) with the later appearance of panic disorder. In rodents, neonatal maternal separation and maternal deprivation (MD) are reported to increase the expression of anxiety-related defensive responses in adult animals. However, little is known about the long-term consequences of these early-life stressors in animal models of panic. We here investigated the effects of a single 24 h-episode of MD on post-natal day 11 (PND 11) in adult male Wistar rats submitted to two animal models that associate escape expression with panic attacks: the elevated T-maze and exposure to severe hypoxia (7% O
    MeSH term(s) Animals ; Animals, Newborn ; Escape Reaction ; Fenclonine ; Hypoxia ; Male ; Maternal Deprivation ; Panic ; Periaqueductal Gray ; Rats ; Rats, Wistar ; Serotonin
    Chemical Substances Serotonin (333DO1RDJY) ; Fenclonine (R5J7E3L9SP)
    Language English
    Publishing date 2022-07-28
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 449927-x
    ISSN 1872-7549 ; 0166-4328
    ISSN (online) 1872-7549
    ISSN 0166-4328
    DOI 10.1016/j.bbr.2022.114031
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Neuroprotection and gliosis attenuation by intravenous application of human mesenchymal stem cells (hMSC) following ventral root crush in mice.

    Cartarozzi, Luciana Politti / Perez, Matheus / Fernandes, Gabriel Gripp / Chiarotto, Gabriela Bortolança / Luzo, Ângela Cristina Malgeiros / Campos, Alline Cristina / Kirchhoff, Frank / de Oliveira, Alexandre Leite Rodrigues

    Molecular and cellular neurosciences

    2021  Volume 118, Page(s) 103694

    Abstract: Rupture and stretching of spinal roots are common incidents that take place in high-energy accidents. The proximal axotomy of motoneurons by crushing of ventral roots is directly related to the degeneration of half of the lesioned population within the ... ...

    Abstract Rupture and stretching of spinal roots are common incidents that take place in high-energy accidents. The proximal axotomy of motoneurons by crushing of ventral roots is directly related to the degeneration of half of the lesioned population within the first two weeks. Moreover, only a small percentage of surviving motoneurons can successfully achieve regeneration after such a proximal lesion, and new treatments are necessary to improve this scenario. In this sense, mesenchymal stem cells (MSC) are of great interest once they secrete a broad spectrum of bioactive molecules that are immunomodulatory and can restore the environment after a lesion. The present work aimed at studying the effects of human mesenchymal stem cells (hMSC) therapy after ventral root crush (VRC) in mice. We evaluated motoneuron survival, glial reaction, and synapse preservation at the ventral horn. For this purpose, C57BL/6 J were submitted to a crush procedure of L4 to L6 ventral roots and treated with a single intravenous injection of adipose-derived hMSC. Evaluation of the results was carried out at 7, 14, and 28 days after injury. Analysis of motoneuron survival and astrogliosis showed that hMSC treatment resulted in higher motoneuron preservation (motoneuron survival ipsi/contralateral ratio: VRC group = 53%, VRC + hMSC group = 66%; p < 0.01), combined with reduction of astrogliosis (ipsi/contralateral GFAP immunolabeling: VRC group = 470%, VRC + hMSC group = 250%; p < 0.001). The morphological classification and Sholl analysis of microglial activation revealed that hMSC treatment reduced type V and increased type II profiles, indicating an enhancement of surveying over activated microglial cells. The glial reactivity modulation directly influenced synaptic inputs in apposition to axotomized motoneurons. In the hMSC-treated group, synaptic maintenance was increased (ipsi/contralateral synaptophysin immunolabeling: VRC group = 53%, VRC + hMSC group = 64%; p < 0.05). Overall, the present data show that intravenous injection of hMSC has neuroprotective and anti-inflammatory effects, decreasing reactive astrogliosis, and microglial reaction. Also, such cell therapy results in motoneuron preservation, combined with significant maintenance of spinal cord circuits, in particular those related to the ventral horn.
    MeSH term(s) Animals ; Gliosis/therapy ; Humans ; Mesenchymal Stem Cells ; Mice ; Mice, Inbred C57BL ; Neuroprotection ; Spinal Cord ; Spinal Nerve Roots/injuries ; Spinal Nerve Roots/pathology
    Language English
    Publishing date 2021-12-24
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1046640-x
    ISSN 1095-9327 ; 1044-7431
    ISSN (online) 1095-9327
    ISSN 1044-7431
    DOI 10.1016/j.mcn.2021.103694
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Cannabidiol Confers Neuroprotection in Rats in a Model of Transient Global Cerebral Ischemia: Impact of Hippocampal Synaptic Neuroplasticity.

    Meyer, Erika / Bonato, Jéssica Mendes / Mori, Marco Aurélio / Mattos, Bianca Andretto / Guimarães, Francisco Silveira / Milani, Humberto / de Campos, Alline Cristina / de Oliveira, Rúbia Maria Weffort

    Molecular neurobiology

    2021  Volume 58, Issue 10, Page(s) 5338–5355

    Abstract: Evidence for the clinical use of neuroprotective drugs for the treatment of cerebral ischemia (CI) is still greatly limited. Spatial/temporal disorientation and cognitive dysfunction are among the most prominent long-term sequelae of CI. Cannabidiol (CBD) ...

    Abstract Evidence for the clinical use of neuroprotective drugs for the treatment of cerebral ischemia (CI) is still greatly limited. Spatial/temporal disorientation and cognitive dysfunction are among the most prominent long-term sequelae of CI. Cannabidiol (CBD) is a non-psychotomimetic constituent of Cannabis sativa that exerts neuroprotective effects against experimental CI. The present study investigated possible neuroprotective mechanisms of action of CBD on spatial memory impairments that are caused by transient global cerebral ischemia (TGCI) in rats. Hippocampal synaptic plasticity is a fundamental mechanism of learning and memory. Thus, we also evaluated the impact of CBD on neuroplastic changes in the hippocampus after TGCI. Wistar rats were trained to learn an eight-arm aversive radial maze (AvRM) task and underwent either sham or TGCI surgery. The animals received vehicle or 10 mg/kg CBD (i.p.) 30 min before surgery, 3 h after surgery, and then once daily for 14 days. On days 7 and 14, we performed a retention memory test. Another group of rats that received the same pharmacological treatment was tested in the object location test (OLT). Brains were removed and processed to assess neuronal degeneration, synaptic protein levels, and dendritic remodeling in the hippocampus. Cannabidiol treatment attenuated ischemia-induced memory deficits. In rats that were subjected to TGCI, CBD attenuated hippocampal CA1 neurodegeneration and increased brain-derived neurotrophic factor levels. Additionally, CBD protected neurons against the deleterious effects of TGCI on dendritic spine number and the length of dendritic arborization. These results suggest that the neuroprotective effects of CBD against TGCI-induced memory impairments involve changes in synaptic plasticity in the hippocampus.
    MeSH term(s) Animals ; Cannabidiol/pharmacology ; Cannabidiol/therapeutic use ; Disease Models, Animal ; Hippocampus/drug effects ; Hippocampus/metabolism ; Hippocampus/pathology ; Ischemic Attack, Transient/metabolism ; Ischemic Attack, Transient/pathology ; Ischemic Attack, Transient/prevention & control ; Male ; Neuronal Plasticity/drug effects ; Neuronal Plasticity/physiology ; Neuroprotection/drug effects ; Neuroprotection/physiology ; Organ Culture Techniques ; Rats ; Rats, Wistar ; Spatial Memory/drug effects ; Spatial Memory/physiology ; Synapses/drug effects ; Synapses/metabolism ; Synapses/pathology
    Chemical Substances Cannabidiol (19GBJ60SN5)
    Language English
    Publishing date 2021-07-24
    Publishing country United States
    Document type Journal Article
    ZDB-ID 645020-9
    ISSN 1559-1182 ; 0893-7648
    ISSN (online) 1559-1182
    ISSN 0893-7648
    DOI 10.1007/s12035-021-02479-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids.

    Campos, Alline Cristina / Guimarães, Francisco Silveira

    Progress in neuro-psychopharmacology & biological psychiatry

    2009  Volume 33, Issue 8, Page(s) 1517–1521

    Abstract: Several studies have shown anxiolytic effects of cannabinoids after systemic or central injections. The periaqueductal gray matter is a midbrain structure involved in the control of anxiety states. Intra-cerebral administration of cannabidiol, a ... ...

    Abstract Several studies have shown anxiolytic effects of cannabinoids after systemic or central injections. The periaqueductal gray matter is a midbrain structure involved in the control of anxiety states. Intra-cerebral administration of cannabidiol, a phytocannabinoid, or anandamide, an endocannabinoid, into the dorsolateral portion of periaqueductal gray (dlPAG) promotes anxiolytic-like effects in several animal models of anxiety with bell-shaped dose-response curves. The reasons for these curves are still unclear, but since these drugs can also activate TRPV1 receptors and increase glutamate release, we hypothesized that, at high doses, cannabidiol and WIN 55,212-2, a CB1 receptor agonist, could activate TRPV1 receptors, facilitating glutamate neurotransmission and anxiety responses. To test this hypothesis male Wistar rats with cannulae aimed toward the dlPAG were submitted to the following intra-dlPAG treatments: Experiment 1. Vehicle (0.2 microL) or WIN 55,212-2 (3-30 pmol); Experiment 2. Capsazepine (CPZ, 10 nmol, a TRPV1 receptor antagonist) or vehicle followed, 5 min later, by vehicle or WIN 55, 212-2 (10 or 30 pmol); Experiment 3. CPZ (10 nmol) or vehicle followed, 5 min later, by cannabidiol (30 or 60 nmol). Ten minutes after the last injection the animals were tested in the elevated plus maze (EPM). WIN 55,212-2 and cannabidiol induced anxiolytic effects at lower doses that disappeared at the higher dose. Although CPZ+WIN 10 or CPZ+WIN 30 pmol groups were not different from control (CPZ+V), capsazepine prevented the decrease in open arm exploration caused by the higher of dose of WIN 55,212-2 (30 nmol) relative to the lower dose of WIN 55,212-2 (10 nmol) and, in the case of cannabidiol (60 nmol), increased open arm exploration (V+CBD 60 group versus CPZ+CBD 60 group). These results suggest that TRPV1 receptors in the dlPAG modulate anxiety and that activation of these receptors by high doses of cannabinoids could be involved in the bell-shaped dose-response curves observed with these compounds.
    MeSH term(s) Analgesics/administration & dosage ; Analysis of Variance ; Animals ; Anxiety/drug therapy ; Anxiety/pathology ; Arachidonic Acids/therapeutic use ; Benzoxazines/administration & dosage ; Cannabinoid Receptor Modulators/agonists ; Cannabinoid Receptor Modulators/antagonists & inhibitors ; Cannabinoid Receptor Modulators/therapeutic use ; Capsaicin/administration & dosage ; Capsaicin/analogs & derivatives ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Endocannabinoids ; Male ; Microinjections/methods ; Morpholines/administration & dosage ; Naphthalenes/administration & dosage ; Periaqueductal Gray/drug effects ; Polyunsaturated Alkamides/therapeutic use ; Rats ; Rats, Wistar ; TRPV Cation Channels/physiology ; Time Factors
    Chemical Substances Analgesics ; Arachidonic Acids ; Benzoxazines ; Cannabinoid Receptor Modulators ; Endocannabinoids ; Morpholines ; Naphthalenes ; Polyunsaturated Alkamides ; TRPV Cation Channels ; Trpv1 protein, rat ; (3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone (5H31GI9502) ; capsazepine (LFW48MY844) ; Capsaicin (S07O44R1ZM) ; anandamide (UR5G69TJKH)
    Language English
    Publishing date 2009-09-06
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 781181-0
    ISSN 1878-4216 ; 0278-5846
    ISSN (online) 1878-4216
    ISSN 0278-5846
    DOI 10.1016/j.pnpbp.2009.08.017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial.

    Rocha, Juliana Mendes / Rossi, Giordano Novak / de Lima Osório, Flávia / Bouso, José Carlos / de Oliveira Silveira, Gabriela / Yonamine, Mauricio / Campos, Alline Cristina / Bertozi, Giuliana / Cecílio Hallak, Jaime E / Dos Santos, Rafael G

    Journal of clinical psychopharmacology

    2021  Volume 41, Issue 3, Page(s) 267–274

    Abstract: Background: The recognition of emotions in facial expressions (REFE) is a core aspect of social cognition. Previous studies with the serotonergic hallucinogens lysergic acid diethylamide and psilocybin showed that these drugs reduced the recognition of ... ...

    Abstract Background: The recognition of emotions in facial expressions (REFE) is a core aspect of social cognition. Previous studies with the serotonergic hallucinogens lysergic acid diethylamide and psilocybin showed that these drugs reduced the recognition of negative (fear) faces in healthy volunteers. This trial assessed the acute and prolonged effects of a single dose of ayahuasca on the REFE.
    Methods: Twenty-two healthy volunteers participated in a pilot, proof-of-concept, randomized trial. Study variables included a REFE task performed before and 4 hours after drug intake, subjective effects (self-reports/observer impressions), tolerability measures (cardiovascular measures, self-reports), and brain-derived neurotrophic factor plasma levels. The REFE task was applied again 1, 7, 14, and 21 days and 3 months after drug intake. Stability of ayahuasca alkaloids during the study was also assessed (room temperature, 18 months).
    Findings: Compared with placebo, ayahuasca did not modify the REFE. No significant effects were observed on cardiovascular measures and brain-derived neurotrophic factor levels. Volunteers reported visual effects, tranquility/relaxation, and well-being, with few reports of transient anxiety/confusion. Ayahuasca was well tolerated, producing mainly nausea, gastrointestinal discomfort, and vomiting. A significant time-dependent deterioration of alkaloids was observed, especially for dimethyltryptamine.
    Conclusions: Absence of significant effects on the REFE task could be due to lack of effects of ayahuasca (at the doses used), alkaloid degradation, learning effects, and the high educational level of the sample. Further trials with different samples are needed to better understand the effects of ayahuasca and other serotonergic hallucinogens on the REFE. Future trials should improve methods to guarantee the stability of ayahuasca alkaloids.
    MeSH term(s) Adult ; Banisteriopsis/chemistry ; Double-Blind Method ; Facial Recognition/drug effects ; Female ; Hallucinogens/pharmacology ; Humans ; Male ; Middle Aged ; Pilot Projects ; Plant Preparations/pharmacology ; Proof of Concept Study ; Time Factors ; Young Adult
    Chemical Substances Hallucinogens ; Plant Preparations
    Language English
    Publishing date 2021-04-12
    Publishing country United States
    Document type Journal Article ; Randomized Controlled Trial
    ZDB-ID 604631-9
    ISSN 1533-712X ; 0271-0749
    ISSN (online) 1533-712X
    ISSN 0271-0749
    DOI 10.1097/JCP.0000000000001396
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Role of 5-HT

    Vilela-Costa, Heloisa H / Maraschin, Jhonatan Christian / Casarotto, Plinio C / Sant'Ana, Ana Beatriz / de Bortoli, Valquiria C / Vicente, Maria Adrielle / Campos, Alline Cristina / Guimarães, Francisco S / Zangrossi, Helio

    Behavioural brain research

    2021  Volume 404, Page(s) 113159

    Abstract: Antidepressant drugs are first-line treatment for panic disorder. Facilitation of 5- ... ...

    Abstract Antidepressant drugs are first-line treatment for panic disorder. Facilitation of 5-HT
    MeSH term(s) Aminopyridines/pharmacology ; Animals ; Antidepressive Agents/pharmacology ; Anxiety/drug therapy ; Blotting, Western ; Elevated Plus Maze Test ; Fluoxetine/pharmacology ; Imipramine/pharmacology ; Indoles/pharmacology ; Male ; Open Field Test/drug effects ; Panic/drug effects ; Periaqueductal Gray/drug effects ; Periaqueductal Gray/metabolism ; Periaqueductal Gray/physiology ; Piperazines/pharmacology ; Pyridines/pharmacology ; Rats ; Rats, Wistar ; Receptor, Serotonin, 5-HT1A/drug effects ; Receptor, Serotonin, 5-HT1A/metabolism ; Receptor, Serotonin, 5-HT1A/physiology ; Receptor, Serotonin, 5-HT2C/drug effects ; Receptor, Serotonin, 5-HT2C/metabolism ; Receptor, Serotonin, 5-HT2C/physiology ; Serotonin 5-HT1 Receptor Antagonists/pharmacology
    Chemical Substances 6-chloro-5-methyl-1-((2-(2-methylpyrid-3-yloxy)pyrid-5-yl)carbamoyl)indoline ; Aminopyridines ; Antidepressive Agents ; Indoles ; Piperazines ; Pyridines ; Receptor, Serotonin, 5-HT2C ; Serotonin 5-HT1 Receptor Antagonists ; Fluoxetine (01K63SUP8D) ; Receptor, Serotonin, 5-HT1A (112692-38-3) ; N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide (71IH826FEG) ; Imipramine (OGG85SX4E4)
    Language English
    Publishing date 2021-02-08
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 449927-x
    ISSN 1872-7549 ; 0166-4328
    ISSN (online) 1872-7549
    ISSN 0166-4328
    DOI 10.1016/j.bbr.2021.113159
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Cannabidiol as an Adjunctive Treatment for Acute Bipolar Depression: A Pilot Study: Le cannabidiol comme traitement d'appoint de la dépression bipolaire aiguë : une étude pilote.

    Pinto, Jairo Vinícius / Crippa, José Alexandre S / Ceresér, Keila Maria / Vianna-Sulzbach, Miréia Fortes / Silveira Júnior, Érico de Moura / Santana da Rosa, Gabriel / Testa da Silva, Manoella Guatimuzim / Hizo, Gabriel Henrique / Simão Medeiros, Leonardo / Santana de Oliveira, Carlos Eduardo / Bristot, Giovana / Campos, Alline Cristina / Guimarães, Francisco Silveira / Hallak, Jaime E C / Zuardi, Antonio W / Yatham, Lakshmi N / Kapczinski, Flávio / Kauer-Sant'Anna, Márcia

    Canadian journal of psychiatry. Revue canadienne de psychiatrie

    2023  Volume 69, Issue 4, Page(s) 242–251

    Abstract: Objective: The treatment of bipolar depression remains challenging due to the limited effective and safe therapeutic options available; thus, developing newer treatments that are effective and well tolerable is an urgent unmet need. The objective of the ...

    Abstract Objective: The treatment of bipolar depression remains challenging due to the limited effective and safe therapeutic options available; thus, developing newer treatments that are effective and well tolerable is an urgent unmet need. The objective of the present trial was to test 150 to 300 mg/day of cannabidiol as an adjunctive treatment for bipolar depression.
    Method: A randomized, double-blind, placebo-controlled pilot study to assess the efficacy of adjunctive cannabidiol in bipolar depression was used. Efficacy parameters were changes in the Montgomery-Åsberg Depression Rating Scale (MADRS) from baseline to week 8. Secondary outcomes included response and remission rates, changes in anxiety and psychotic symptoms, and changes in functioning. Patients continued double-blind treatment until week 12 to monitor for adverse effects, laboratory analysis, and manic symptoms. Study registry: NCT03310593.
    Results: A total of 35 participants were included. MADRS scores significantly decreased from baseline to the endpoint (placebo, -14.56; cannabidiol, -15.38), but there was no significant difference between the groups. Similarly, there were no other significant effects on the secondary outcomes. However, an exploratory analysis showed a significant effect of cannabidiol 300 mg/day in reducing MADRS scores from week 2 to week 8 (placebo, -6.64; cannabidiol, -13.72). There were no significant differences in the development of manic symptoms or any other adverse effects.
    Conclusion: Cannabidiol did not show significantly higher adverse effects than placebo. Despite the negative finding on the primary outcome, an exploratory analysis suggested that cannabidiol should be further studied in bipolar depression in higher doses of at least 300 mg/day and under research designs that could better control for high placebo response.
    MeSH term(s) Humans ; Bipolar Disorder/drug therapy ; Cannabidiol/pharmacology ; Cannabidiol/therapeutic use ; Pilot Projects ; Depression ; Psychotic Disorders/drug therapy ; Double-Blind Method ; Treatment Outcome
    Chemical Substances Cannabidiol (19GBJ60SN5)
    Language English
    Publishing date 2023-11-03
    Publishing country United States
    Document type Randomized Controlled Trial ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 304227-3
    ISSN 1497-0015 ; 0008-4824 ; 0706-7437
    ISSN (online) 1497-0015
    ISSN 0008-4824 ; 0706-7437
    DOI 10.1177/07067437231209650
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top